Tropicamide

Subscribe to Selected New Research on Tropicamide

144 relevant articles (7 outcomes, 21 trials/studies) found for this Drug

Description: One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.

Also Known As:

Akorn Brand of Tropicamide; Alcon Brand of Tropicamide; Bausch & Lomb Brand of Tropicamide; Bournonville Brand of Tropicamide; Cahill May Roberts Brand of Tropicamide; Chauvin Brand of Tropicamide; Colircusi Tropicamida; Medical Ophthalmics Brand of Tropicamide; Minims Tropicamide; Mydral; Mydriafair; Mydriaticum; Mydrum; N-Ethyl-N-(4-pyridylmethyl)tropamide; N-Ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)benzeneacetamide; Novartis Brand of Tropicamide; Ocu-Tropic; Ocumed Brand of Tropicamide; Ocusoft Brand of Tropicamide; Pharmafair Brand of Tropicamide; Rivex Brand of Tropicamide; Stulln Brand of Tropicamide; Triaminic DM; Tropicacyl; Tropicamide Faure; Tropicamide Minims; Tropicamide Monofree; Tropicamide Monohydrochloride, (R)-Isomer; Tropicamide Monohydrochloride, (S)-Isomer; Tropicamide, (+-)-Isomer; Tropicamide, (R)-Isomer; Tropicamide, (S)-Isomer; DM, Triaminic; Faure, Tropicamide; Minims, Tropicamide; Monofree, Tropicamide; Ocu Tropic; OcuTropic; Tropicamida, Colircusi; Tropicamide Akorn Brand; Tropicamide Alcon Brand; Tropicamide Bournonville Brand; Tropicamide Chauvin Brand; Tropicamide Novartis Brand; Tropicamide Ocumed Brand; Tropicamide Ocusoft Brand; Tropicamide Pharmafair Brand; Tropicamide Rivex Brand; Tropicamide Stulln Brand; Tropicamide, Minims; Benzeneacetamide, N-ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)-

Relationship Network

Drug Context: Research Results

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Pyridines: 26

Tropicamide: 144

phenyltrope: 1

Experts

1.	Iribarren, Rafael: 1 article (06/2008)
2.	Weber, Suzanne M: 1 article (10/2007)
3.	Burgos, Melissa: 1 article (10/2007)
4.	Salamone, John D: 1 article (10/2007)
5.	Betz, Adrienne J: 1 article (10/2007)
6.	McLaughlin, Peter J: 1 article (10/2007)
7.	Krumholz, David M: 1 article (05/2007)
8.	Portello, Joan K: 1 article (05/2007)
9.	Rosenfield, Mark: 1 article (05/2007)
10.	Haddad, David E: 1 article (05/2007)

Related Diseases

1.	Mydriasis 08/01/1995 - "The aim of this study was to investigate the effect of nasolacrimal occlusion on tropicamide-induced mydriasis" 05/01/2007 - "Does prior instillation of a topical anaesthetic alter the pupillary mydriasis produced by tropicamide (0.5%)?" 04/01/2006 - "Intraocular pressure change following application of 1% tropicamide for diagnostic mydriasis." 02/01/2003 - "PURPOSE: To compare the mydriatic effect and safety between different concentrations of tropicamide and phenyle-phrine in preoperative mydriasis for phaco-emulsification" 06/01/2002 - "Although tropicamide-induced mydriasis was observed in the treated eye, the contralateral eye did not show any changes in pupillary function at any time" Order ALL the reference details at left...
2.	Alzheimer Disease (Alzheimer's Disease) 06/01/1997 - "CONCLUSION: Results of this study indicate that pupil measurement after instillation of tropicamide cannot be used as a reliable diagnostic test for Alzheimer's disease" 06/01/1996 - "We performed a masked study involving 17 patients with Alzheimer's disease and 20 mentally healthy controls with respect to the pupillary response induced by tropicamide" 02/01/2008 - "Previous research demonstrated that it is possible to distinguish patients with probable Alzheimer's disease from age-matched controls based on an exaggerated pupil dilation response to dilute tropicamide" 01/01/2006 - "RATIONALE: Patients suffering from Alzheimer's disease (AD) may show increased sensitivity to tropicamide, a muscarinic cholinoceptor antagonist" 10/01/2003 - "Re-evaluation of tropicamide in the pupillary response test for Alzheimer's disease." Order ALL the reference details at left...
3.	Refractive Errors (Refractive Error) 07/01/2001 - "To evaluate the cycloplegic effect of 1% tropicamide in myopic children and to determine whether its efficacy is associated with age, gender, iris color, ethnicity, magnitude of the refractive error, or latent error" 02/01/1984 - "The pre- and post-test refractive errors at distance were determined using 1% tropicamide HCl" 04/01/2001 - "CONCLUSION: Our results suggest that tropicamide is as effective as cyclopentolate for the measurement of refractive error in most healthy, nonstrabismic infants." 12/01/2003 - "The refractive error was determined using cyclopentolate and tropicamide as cycloplegic agents and compared to that determined in a non-cycloplegic situation" 04/01/2001 - "The mean refractive error was +1.81 D (+/-1.19 D) with tropicamide and +1.88 D (+/-1.45 D) with cyclopentolate" Order ALL the reference details at left...
4.	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 03/01/1997 - "The anticholinergic agent tropicamide causes a significantly greater change in the pupil diameter of patients with Alzheimer's disease (AD) than in that of patients with alcoholic or vascular dementia or in normal controls" 09/01/1998 - "We tested the pupillary response to the instillation of 0.01% tropicamide in 48 subjects: 15 patients with probable or possible Alzheimer's disease, five patients with vascular dementia (VD), 16 elderly controls (EC) and 12 young controls (YC)" 03/01/1997 - "Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia." 10/01/2003 - "When the tropicamide concentration was diluted to half of the initial concentration and performed for AD (n=14), vascular dementia (VD) (n=14), and young (n=16) subjects, the AD subjects showed a large dilation (mean pupil dilation rate: 133.8+/-15%) while the non-AD subjects did not show hypersensitivity to the new concentration of eye drops (105.4+/-9%)" Order ALL the reference details at left...
5.	Pain (Aches) 02/01/1996 - "Treatment with 0.5% tropicamide ophthalmic solution was effective in decreasing ocular pain." 05/01/2004 - "Pain was significantly less when the lower concentration of tropicamide was used; pain score for the 0.5% group [median (interquartile range)] 1.0 (0-2) and 2.0 (1-3) for the 1.0% group, P = 0.009 (Wilcoxon rank test)" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Phenylephrine (Neo-Synephrine)
2.	Cyclopentolate (Cyclogyl)
3.	dapiprazole (Rev-Eyes)
4.	Ophthalmic Solutions (Eye Drops)
5.	ibopamine
6.	Fluorescein (Funduscein)
7.	Atropine (Hyoscyamine)
8.	Moxisylyte (Thymoxamine)
9.	Cholinergic Antagonists (Anticholinergics)
10.	p-Hydroxyamphetamine (Hydroxyamfetamine)

Related Therapies and Procedures

1.	Lenses
2.	Cataract Extraction
3.	Meridians (Jing Luo)
4.	Lasers (Laser)
5.	Phacoemulsification

Best Treatments:
Research Summary Report
on Mydriasis

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 35 Outcomes
Top 200 Key Drugs and Biologics
Top 46 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>